Autopsy report · NCT03274401

Screening for Atrial Fibrillation in Pulmonary Embolism Study -SAFE-PE Study

“Due to Covid-19”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 7 months before it stopped.
• 90 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Danderyd Hospital

Sponsor type

University, hospital or other

Conditions

Atrial Fibrillation; Pulmonary Embolism

Interventions

Zenicor intermittent ECG device; 5 day ECG patch

Participants

90

Sites

1

Countries

Sweden

Trials that died the same way

• Low Intensity Shockwaves Therapy for the Treatment of Erectile Dysfunction. 12- Month Follow-Up
  “Due to COVID-19 Pandemic” (93% match in meaning)
• Microbiological Evaluation of Single Versus Multiple Visits Regeneration Using MALDI-TOF Mass Spectrometry
  “due to the COVID-19 pandemic” (92% match in meaning)
• Virtual Reality for the Treatment of Chronic Low Back Pain
  “Due to the impact of COVID-19” (90% match in meaning)
• Yogurt Supplementation to Alter Bone Biomarkers, the Gut Microbiota and Inflammation in Older Adults
  “Due to the onset of the COVID-19 pandemic” (86% match in meaning)
• Effect of Global Postural Re-education in Idiopathic Scoliosis
  “Because of the COVID-19 pandemic” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.